91 related articles for article (PubMed ID: 9949299)
1. Infrequent presence of anti-c-Myc antibodies and absence of c-Myc oncoprotein in sera from lung cancer patients.
Yamamoto A; Shimizu E; Takeuchi E; Houchi H; Doi H; Bando H; Ogura T; Sone S
Oncology; 1999; 56(2):129-33. PubMed ID: 9949299
[TBL] [Abstract][Full Text] [Related]
2. Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients.
Yamamoto A; Shimizu E; Ogura T; Sone S
Int J Cancer; 1996 Aug; 69(4):283-9. PubMed ID: 8797869
[TBL] [Abstract][Full Text] [Related]
3. Presence of antibodies against retinoblastoma tumor suppressor protein in patients with lung cancer.
Matsumoto S; Teramoto H; Nakamoto M; Igishi T; Kawasaki Y; Shimizu E
Int J Oncol; 2001 Nov; 19(5):1035-9. PubMed ID: 11605006
[TBL] [Abstract][Full Text] [Related]
4. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.
Looi K; Megliorino R; Shi FD; Peng XX; Chen Y; Zhang JY
Oncol Rep; 2006 Nov; 16(5):1105-10. PubMed ID: 17016600
[TBL] [Abstract][Full Text] [Related]
5. Analysis of antibodies to p16INK4A tumor suppressor gene products in lung cancer patients.
Namikawa O; Shimizu E; Sumitomo K; Sone S
Int J Oncol; 1999 Apr; 14(4):681-5. PubMed ID: 10087314
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection.
Megliorino R; Shi FD; Peng XX; Wang X; Chan EK; Tan EM; Zhang JY
Cancer Detect Prev; 2005; 29(3):241-8. PubMed ID: 15896923
[TBL] [Abstract][Full Text] [Related]
7. L-Myc overexpression and detection of auto-antibodies against L-Myc in both the serum and pleural effusion from a patient with non-small cell lung cancer.
Yamamoto A; Shimizu E; Sumitomo K; Shinohara A; Namikawa O; Uehara H; Sone S
Intern Med; 1997 Oct; 36(10):724-7. PubMed ID: 9372336
[TBL] [Abstract][Full Text] [Related]
8. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
Vural B; Chen LC; Saip P; Chen YT; Ustuner Z; Gonen M; Simpson AJ; Old LJ; Ozbek U; Gure AO
Cancer; 2005 Jun; 103(12):2575-83. PubMed ID: 15880380
[TBL] [Abstract][Full Text] [Related]
9. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
[TBL] [Abstract][Full Text] [Related]
10. Circulating antibodies to p40(AIS) in the sera of respiratory tract cancer patients.
Yamaguchi K; Patturajan M; Trink B; Usadel H; Koch W; Jen J; Sidransky D
Int J Cancer; 2000 Nov; 89(6):524-8. PubMed ID: 11102898
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to c-myc protein: elevated levels in patients with African Burkitt's lymphoma and normal Ghanians.
LaFond RE; Eaton RB; Watt RA; Villee CA; Actor JK; Schur PH
Autoimmunity; 1992; 13(3):215-24. PubMed ID: 1472633
[TBL] [Abstract][Full Text] [Related]
12. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure.
Chapman CJ; Murray A; McElveen JE; Sahin U; Luxemburger U; Türeci O; Wiewrodt R; Barnes AC; Robertson JF
Thorax; 2008 Mar; 63(3):228-33. PubMed ID: 17932110
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma.
Chen G; Wang X; Yu J; Varambally S; Yu J; Thomas DG; Lin MY; Vishnu P; Wang Z; Wang R; Fielhauer J; Ghosh D; Giordano TJ; Giacherio D; Chang AC; Orringer MB; El-Hefnawy T; Bigbee WL; Beer DG; Chinnaiyan AM
Cancer Res; 2007 Apr; 67(7):3461-7. PubMed ID: 17409457
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating antibodies against c-myc protein in cancer patient sera.
Ben-Mahrez K; Thierry D; Sorokine I; Danna-Muller A; Kohiyama M
Br J Cancer; 1988 Jun; 57(6):529-34. PubMed ID: 3044429
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of paraneoplastic polyneuropathy in patients with breast cancer and small cell lung cancer].
Koroleva ES; Losenkov IS; Alifirova VM; Ivanova SA; Goldberg VE; Novikova NS
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):93-6. PubMed ID: 24874327
[TBL] [Abstract][Full Text] [Related]
17. Development of a polyclonal antibody with defined specificity against synthetic peptides from the N-myc oncoprotein using multiple antigen peptide and hemocyanin conjugation methods.
Yang HW; Ikeda H; Kato K; Nakagawara A; Choi SH; Hayashi Y; Obana K; Hemmi H; Tsuchida Y
J Pediatr Surg; 1999 Mar; 34(3):454-60. PubMed ID: 10211653
[TBL] [Abstract][Full Text] [Related]
18. Serum antibodies to retinal antigens in lung cancer and sarcoidosis.
Jankowska R; Witkowska D; Porebska I; Kuropatwa M; Kurowska E; Gorczyca WA
Pathobiology; 2004; 71(6):323-8. PubMed ID: 15627843
[TBL] [Abstract][Full Text] [Related]
19. c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model.
Sekhon HS; London CA; Sekhon M; Iversen PL; Devi GR
Lung Cancer; 2008 Jun; 60(3):347-54. PubMed ID: 18096271
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor and anti-ovarian autoantibodies in women with ovarian cancer.
Barua A; Bradaric MJ; Kebede T; Espionosa S; Edassery SL; Bitterman P; Rotmensch J; Luborsky JL
Am J Reprod Immunol; 2007 Apr; 57(4):243-9. PubMed ID: 17362385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
